Cannabis Campaigners' Guide News Database result:


After you have finished reading this article you can click here to go back.

Company testing cannabis-based drug

Pem McNerney

HealthScout

Tuesday 08 May 2001

---
Britain's GW Pharmaceuticals will begin clinical trials in Canada for a
cannabis-based drug that could help people suffering from multiple
sclerosis and other medical conditions that cause pain.
According to an article from the CBC News, the company has received
approval to begin Phase III trials, the last hurdle before drug makers can
offer a drug to the public. The trials will involve a wide range of
patients in several locations, the story says.

Cannabinoids, the active ingredients in marijuana, help prevent pain.
People using marijuana to treat medical conditions generally have to buy it
illegally, the article says.

The new drug is sprayed under the tongue. It relieves the pain and spasms
of multiple sclerosis, and pain from spinal-cord injuries, say company
officials quoted in the article.

 

 

 

After you have finished reading this article you can click here to go back. 




This page was created by the Cannabis Campaigners' Guide.

Feel free to link to this page!